Arkolith/Insider Trading/BBOT/Form 4

Chen Bihua

Director, 10% OwnerBridgeBio Oncology Therapeutics, Inc. (BBOT) · full profile →Form 4 · filed Jul 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Other(J)4.5M—$00
Jul 1, 2026Other(J)2.7M—$04.9M
Jul 1, 2026Other(J)1.7M—$05.0M
Jul 1, 2026Other(J)131K—$06.1M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-075538) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML